Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1029 | Thyroid (non-cancer) | ECE2018

Single session treatment of benign thyroid nodules with radiofrecuency ablation: results at 6 months in 17 patients

Familiar Cristina , Merino Salome , Ganado Tomas , Jimenez Ines , Sanabria Concepcion

Introduction: Radiofrecuency ablation (RFA) represents an alternative to surgery for benign thyroid nodules with pressure symptoms or evident progressive growth.Objetives: To analyze in our center the efficacy and safety at 6 montns of a single session treatment of RFA performed in predominantly solid thyroid nodules.Patients and methods: 17 patients with citologically benign thyroid nodules with pressure symptoms (dysphonia, dyspn...

ea0056p1128 | Thyroid cancer | ECE2018

Highly sensitive Thyroglobulin assay in monitoring patients treated for differentiated thyoid cancer in 26 consecutive patients

Jimenez Ines , Familiar Cristina , Azcutia Anne , Ramos Elvira , Barrio Elvira

Introduction: Guidelines suggest that serum basal (nonstimulated) thyroblobulin (bTg) with sensitive assays (Functional Sensitivity-FS- below 0.1 or 0.2 ng/ml) could substitute the measurement of serum Tg levels after TSH stimulation during the follow-up of patients with differentiated thyroid cancer (DTC) when basal results fall below the FS.Objective: A sensitive assay for Tg was incorporate in our center (Chemiluminiscent Tg Access; Beckam Coulter; Br...

ea0056p627 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Cross-hormone treatment: review of cardiovascular risk factors and bone mineral density in 25 transsexual subjects followed in a tertiary hospital

Azkutia Ane , Herraiz Lorea , Jimenez Ines , Barrio Elvira , Ramos Elvira , Cuesta Martin , Diaz Angel

Introduction and objectives: Transsexuality refers to discrepancy between the assigned sex/gender at birth and the one that the subject identifies with. The use of the cross hormone treatment as sex/gender change method implies the necessity of monitorize the hormone levels and potential treatment risks. Our study tries to evaluate the relationship between the hormone changes and the changes in the cardiovascular risk factors and the bone mineral density.<p class="abstext"...

ea0056p36 | Adrenal cortex (to include Cushing's) | ECE2018

Hypoaldosteronism induced by trimethroprim: hyponatremia is frequent

Herraiz Lorea , Azcutia Ane , Santiago Alejandro , Miguel Paz de , Crespo Irene , Cuesta Martin , Jimenez Ines , Calle Alfonso , Runkle Isabelle

Introduction: Hypoaldosteronism is characterized by the development of hyperkalemia, but can also induce hypovolemic hyponatremia. Trimethroprim can cause hypoaldosteronism through mineralocorticoid resistance. That hypoaldosteronism can induce hyponatremia in absence of Addison’s disease has been questioned. We studied the electrolyte disturbances found following initiation of trimetroprim therapy.Material and methods: Retrospective, analytical. La...

ea0056oc10.4 | Cardiovascular aspects of endocrine diseases | ECE2018

Improvement in the control of hypertension in diabetic patients screened for hyperaldosteronism

Jimenez Ines , Crespo Irene , Cuesta Martin , Elvira Carlos , de Miguel Paz , Santiago Alejandro , Fernandez Luzdivina , de Parayuelo Maria Victoria Saez , Calle Alfonso , Runkle Isabelle

Introduction: Control of hypertension (HT) is essential to reduce cardiovascular events in diabetic patients (DPts). However, studies indicate that only 50% of DPts with treated hypertension present adequate blood pressure (BP) control. Yet Endocrine-Society-Guideline (ESG) screening for primary hyperaldosteronism (PHA) is rarely applied. Furthermore, in patients with essential hypertension (EH), longer-acting hypertension medication (HM) improves 24-hour BP when compared to r...

ea0056p51 | Adrenal cortex (to include Cushing's) | ECE2018

A descriptive study of patients with adrenocortical carcinoma treated in hospital clinico san carlos (HCSC) over the last 20 years

Barrio Elvira , Ramos Elvira , Miguel Paz de , Diaz J. Angel , Sanabria Concepcion , Cuesta Martin , Jimenez Ines , Espinosa Patricia , Garcia Antonio , Molino Angel

Introduction: Adrenocortical carcinoma (ACC) is a rare and aggressive tumor that accounts for 0.2% of cancer-related deaths. Case series and prospective studies are very limited due to its low prevalence. Current knowledge is based primarily on the opinions of experts in specialized units. The aim of this study is to perform a descriptive analysis of the management and prognosis of patients with ACC in HCSC in the last 20 years.Material and methods: Eigh...

ea0056p1063 | Thyroid (non-cancer) | ECE2018

The accuracy of diagnostic tests in amiodarone-induced thyrotoxicosis; a case-series

Cuesta Martin , Ruiz Cristina Gonzalez , Varas Ines Jimenez , Lapena Luis , Ganado Tomas , Merino Salome , Santiago Alejandro , Recio Lourdes , Pascual Alfonso Luis Calle , Vega Isabelle Runkle de la

Introduction: Amiodarone-induced thyrotoxicosis (AIT) can present a high morbi-mortality.Initial subtype identification facilitates appropriate management.We describe the utility of diagnostic tests in a cohort of patients with AIT.Material and methods: Retrospective, observational study of 59 patients attended from 2007 to 2018 in outpatient clinic. Differential diagnosis: type I if FT4 and FT3 (TH) were normalized following therapy with antithyroid dru...